Address: Insure Insights 61 Bridge Street, Kington.HR5 3DJ United Kingdom

Global Vulvodynia Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Home
  • Reports
  • Global Vulvodynia Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028
Global Vulvodynia Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

Global Vulvodynia Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Published Date: 03 Jul 2021
  • Report ID: HLT 00235
  • Pages: 186
  • Base Year: 2019
  • Format: PDF
  • Historical Data: 2016-2019

According to a study published by Insure Insights, the global vulvodynia market is estimated to grow at a CAGR of 6.7% during the forecast period. Vulvodynia is the condition where there are intense pain and discomfort in the opening of the vulva, the cause of which is still unknown. This condition affects women and makes it difficult and painful for them to have intercourse, socialize, and exercise. Typically, there are two types of vulvodynia, generalized vulvodynia, and localized vulvodynia. Vulvodynia is caused by prolonged sitting, insertion of tampons, the wedding of tight undergarments, sexual intercourse, horseback riding, cycling, and extreme gynecologic examination. The rising number of women suffering from vulvodynia will result in a subsequent increase in the demand for the treatment of vulvodynia. This is estimated to drive the growth of the vulvodynia treatment market.

Top Driver: Growing Awareness About the Burden of Vulvodynia on the Healthcare Systems

Growing awareness about the burden of vulvodynia on the healthcare systems in developed economies is catalyzing the expansion of the vulvodynia treatment market. Also, growing awareness about the diagnostics for vulvodynia among clinicians, especially gynecologists, is fueling the growth of the global vulvodynia treatment market. Evolution in therapeutic interventions for managing vulvodynia is expected to create lucrative avenues in the market. The growing adoption of local anesthetics in the form of gel or cream to manage pain-related distress in the patient populations is a major factor boosting the vulvodynia treatment market. Increasing research activities on expanding first-line treatment for vulvodynia is also propelling market growth. In addition to this, the growing number of psychophysical studies is expected to fulfill unmet needs in the vulvodynia treatment market.

Anti-convulsant Segment is Estimated to Witness Significant Growth During the Forecast Period

The global wound care market has been segmented into local anesthetics, anticonvulsants, tricyclic antidepressants, and others based on the type of drugs. The anti-convulsant segment is estimated to grow at a significant rate during the forecast period. In vulvodynia treatment, anti-convulsant is the most preferred drug. Gabapentin is the most trusted anti-convulsant drug available in vulvodynia treatment. Based on the distribution channel, the market is categorized into hospital pharmacies, mail order pharmacies, and retail pharmacies.

  The Growing Government Investment and Favorable Reimbursement Policies to Benefit North America Market

The global vulvodynia market has been segmented into North America, Europe, Asia Pacific, and SAMEA. The rising concerns related to human health, the growing government investment and initiatives, and favorable reimbursement policies are the factors propelling the growth of the market in the North American region. Following North America, the European market is estimated to proliferate owing to the increasing research activities and the improved healthcare facilities. In the Asia Pacific region, steady market growth is being experienced due to the developing medical infrastructure both in the public and private sectors.

Players to Focus on Product Development

The global vulvodynia market is estimated to stay fragmented during the forecast period owing to the possible new entrants. The major players are adopting various strategies such as product launches, collaborations, mergers & acquisitions, and partnerships, which are contributing to the growth of the vulvodynia treatment market globally. collaborations. The major market players operating in the market include Pfizer Inc., Sanofi Aventis, Eli Lilly and Company, Depomed Inc., Janssen Pharmaceuticals, Inc., Noven Pharmaceuticals, Inc., Upsher-Smith Laboratories, LLC, and others.

Scope of the Report

By Drug Type

  • Local anesthetics
  • Anticonvulsants
  • Tricyclic antidepressants
  • Others

By Distribution Channel    

  • Hospital pharmacies
  • Mail order pharmacies
  • Retail pharmacies.

By Region

  • North America
  • Europe
  • Asia Pacific
  • SAMEA

Key Reasons to Purchase this Report

  1. It provides a technological development map over time to understand the growth rate of the industry.
  2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
  3. It renders definite analysis for changing competitive dynamics.
  4. It builds a seven-year estimate based on how the market is predicted to grow.

Table of Content

Chapter 1           Overview And Scope

1.1             Market Vision

1.1.1          Market Definition

1.1.2          Market Scope

1.2             Market Segmentation

Chapter 2           Our Research Practice

2.1             Our Research Methodology

2.2             Data Triangulation

2.3             Data Sources

2.4             Assumptions for the study

2.5             Approach Adopted

Chapter 3           Executive Summary

3.1             Market Snapshot

3.2             Regional Snapshot

3.3             Segment Summary

Chapter 4           Covid-19 Impact Analysis

4.1             Overview

4.2             Prevalence analysis

4.3             Key Factor Impact Analysis

Chapter 5           Global Sepsis Diagnostic Market Forces

5.1             What’s Driving the Market

5.2             Porter’s Five Forces Analysis

5.2.1          Power of Suppliers

5.2.2          Threats From New Entrants

5.2.3          Power of Buyer

5.2.4          Threat From Substitute Product

5.2.5          Degree of Competition

Chapter 6           Global Sepsis Diagnostic Market -Industry Snapshots

6.1             Overview

6.1.1          Global Sepsis Diagnostic Market Value, 2019 – 2028, (US$ Bn)

6.2             Market Overview

6.2.1          Drivers Analysis

6.2.2          Restraint/Challenges analysis

6.2.3          Opportunity Analysis

6.3             Supply Chain/Value Chain Analysis

6.4             Market SWOT Analysis

Chapter 7           Global Sepsis Diagnostic Market Analysis, by Technology

7.1             Overview

7.2             Key Findings for Sepsis Diagnostic Market- By Technology

7.2.1          Sepsis Diagnostic Market- Molecular diagnostic

7.2.2          Sepsis Diagnostic Market- Immunoassay

7.2.3          Sepsis Diagnostic Market- Microbiology

7.2.4          Sepsis Diagnostic Market- Others

Chapter 8           Global Sepsis Diagnostic Market Analysis, by Product

8.1             Overview

8.2             Key Findings for Sepsis Diagnostic Market- By Product

8.2.1          Sepsis Diagnostic Market- Instruments

8.2.2          Sepsis Diagnostic Market- Assay kits

8.2.3          Sepsis Diagnostic Market- Blood culture media

8.2.4          Sepsis Diagnostic Market- Others

Chapter 9           Global Sepsis Diagnostic Market Analysis, by Diagnostic method

9.1             Overview

9.2             Key Findings for Sepsis Diagnostic Market- By Diagnostic method

9.2.1          Sepsis Diagnostic Market- Laboratory testing

9.2.2          Sepsis Diagnostic Market- PoC testing

Chapter 10       Global Sepsis Diagnostic Market Analysis, by Pathogen

10.1           Overview

10.2           Key Findings for Sepsis Diagnostic Market- By Pathogen

10.2.1       Sepsis Diagnostic Market- Fungal sepsis

10.2.2       Sepsis Diagnostic Market- Bacterial sepsis

10.2.3       Sepsis Diagnostic Market- Others

Chapter 11       Sepsis Diagnostic Market Analysis by Region

11.1           Key Findings for Sepsis Diagnostic Market- By region

11.2           Overview

11.2.1       Global Sepsis Diagnostic Market Analysis, By Technology, 2019 – 2028

11.2.2       Global Sepsis Diagnostic Market Analysis, By Product, 2019 – 2028

11.2.3       Global Sepsis Diagnostic Market Analysis, By Diagnostic method, 2019 – 2028

11.2.4       Global Sepsis Diagnostic Market Analysis, By Pathogen, 2019 – 2028

11.3           Sepsis Diagnostic Market – North America

11.3.1       Overview

11.3.2       U.S.

11.3.3       Canada

11.3.4       Mexico

11.3.5       North America Market, By Technology

11.3.6       North America Market, By Product

11.3.7       North America Market, By Diagnostic method

11.3.8       North America Market, By Pathogen

11.4           Sepsis Diagnostic Market – Europe

11.4.1       Overview

11.4.2       Germany

11.4.3       United Kingdom

11.4.4       France

11.4.5       Italy

11.4.6       Rest Of Europe

11.4.7       Europe Market, By Technology

11.4.8       Europe Market, By Product

11.4.9       Europe market by, Diagnostic method

11.4.10     Europe Market, By Pathogen

11.5           Sepsis Diagnostic Market – Asia Pacific

11.5.1       Overview

11.5.2       China

11.5.3       Japan

11.5.4       India

11.5.5       Rest of APAC

11.5.6       Asia Pacific Market, By Technology

11.5.7       Asia Pacific Market, By Product

11.5.8       Asia Pacific Market, By Diagnostic method

11.5.9       Asia Pacific Market, By Pathogen

11.6           Sepsis Diagnostic Market – SAMEA

11.6.1       Overview

11.6.2       Middle East & Africa (MEA)

11.6.3       South America

11.6.4       Rest Of World

11.6.5       South America, Middle East and Africa Market, By Technology

11.6.6       South America, Middle East and Africa Market, By Product

11.6.7       South America, Middle East and Africa Market, By Diagnostic method

11.6.8       South America, Middle East and Africa Market, By Pathogen

Chapter 12       Market Competition Analysis

12.1           Market Share/Positioning Analysis

12.1.1       Market Positioning of Key Vendors, 2019

12.1.2       Key Strategies Adopted by the Leading Players

12.1.3       Recent Developments

Chapter 13       Company Profiles- Snapshot

13.1           bioMérieux SA

13.1.1       Business Fundamentals

13.1.2       Financial Snapshots

13.1.3       Product Portfolio

13.1.4       Recent Developments

13.2           Beckman Coulter, Inc.

13.3           Becton, Dickinson and Company

13.4           Sysmex Corporation

13.5           F. Hoffmann-La Roche AG

13.6           Thermo Fisher Scientific, Inc.

*More than 10 Companies are profiled in this Research Report*

*Financials would be provided on a best efforts basis for private companies”

Chapter 14       Appendix

 

 

 

Request for Sample

Please fill out the form to receive sample pages of the report